Sign In
Buy RMD
$188.63
+2.34 (+1.26%)
At Close: Jun 18, 2026
ResMed (RMD) Upgraded to Buy: What Does It Mean for the Stock?
01:01pm, Wednesday, 02'nd Oct 2024
ResMed (RMD) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Scoop up These 4 GARP Stocks to Receive Handsome Returns
11:06am, Wednesday, 02'nd Oct 2024
The GARP strategy helps investors gain exposure to stocks that have impressive prospects and are trading at a discount. RACE, VERX, RMD and HUBB are some stocks that hold promise.
RMD Stock Likely to Gain From Enhanced Digital Sleep Health Solutions
10:20am, Tuesday, 01'st Oct 2024
ResMed introduces digital and personalized solutions designed to improve sleep health.
ResMed Unveils 2030 Strategy to Drive Growth, Profitability, and Shareholder Returns
04:05pm, Monday, 30'th Sep 2024
NEW YORK and SAN DIEGO, Sept. 30, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today unveiled its 2030 Strategy to drive growth, profitability, and shareholder returns at an Investor Day in N
UPDATE -- ResMed Unveils New Collection of Digital and Personalized Solutions designed to Improve Sleep Health
09:48am, Monday, 30'th Sep 2024
ResMed makes it easier for people to manage their sleep health and stay on (continuous positive airway pressure) CPAP treatment by integrating its leading myAir ™ consumer app with Apple and Androi
ResMed Enhances CPAP Therapy with its First Fabric Mask, Designed to Make it Easier for People to Embrace Their Treatment and Improve Overall Sleep Health
ResMed Enhances CPAP Therapy with its First Fabric Mask, Designed to Make it Easier for People to Embrace Their Treatment and Improve Overall Sleep Health
ResMed Unveils New Collection of Digital and Personalized Solutions designed to Improve Sleep Health
08:01am, Monday, 30'th Sep 2024
ResMed makes it easier for people to manage their sleep health and stay on (continuous positive airway pressure) CPAP treatment by integrating its leading myAir ™ consumer app with Apple and Androi
ResMed: Growing Returns With Continuous Acquisitions Led To A Margin Of Safety
12:45am, Thursday, 19'th Sep 2024
ResMed achieved double-digit revenue and profit growth over the past 9 years, driven by continuous acquisitions and improving operating efficiencies. ResMed's capital efficiencies showed mixed results
S&P 500 Gains and Losses Today: ResMed Drops as Weight-Loss Drugs Threaten Demand
05:55pm, Wednesday, 18'th Sep 2024
Major U.S. equities indexes ended lower on Wednesday after the Federal Reserve reduced its benchmark interest rate by half a percentage point. Central bank policymakers opted for an aggressive rate cu
Why ResMed Stock Tumbled by 5% Today
05:49pm, Wednesday, 18'th Sep 2024
An analyst downgraded his recommendation on the medical device specialist. He now feels investors should avoid it.
Why ResMed's Rally Is Just Getting Started
11:30am, Wednesday, 18'th Sep 2024
ResMed's impressive turnaround, driven by margin improvements, innovative products, and GLP-1 drug tailwinds, positions it for significant long-term growth and elevated returns. The company's AirSense
Reasons to Retain ResMed Stock in Your Portfolio for Now
09:32am, Wednesday, 11'th Sep 2024
Strong demand for RMD's market-leading mask portfolio raises investors' optimism.
ResMed to Host Its 2024 Investor Day on September 30, 2024, at the New York Stock Exchange
04:05pm, Tuesday, 10'th Sep 2024
SAN DIEGO, Sept. 10, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) will host an investor day on Monday, September 30, 2024, beginning at approximately 1:00 p.m. (Eastern Daylight Time). As pre
Dublin, Sept. 04, 2024 (GLOBE NEWSWIRE) -- The "U.S. Sleep Disorders Treatment Market: Sleep Centers, Sleep Studies & CPAPs" report from Marketdata LLC has been added to ResearchAndMarkets.com's offer
